XBiotech XBIT
NASDAQ XBIT
$2.02 +0.02 (+1.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

XBiotech (XBIT) EBT Margin (2020 - 2022)

Updated

XBiotech's EBT Margin came in at -837.61% for FY2022, down 699.20 percentage points from -138.40% in FY2021.

Analysis

XBiotech (XBIT) EBT Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBT Margin at -138.40% in FY2021 (-109.25 pp) and -29.15% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 26.66%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 25.18%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 18.19%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 27.53%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -131.41%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -4.34%
10 XBiotech 61.59 Mn -473.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -610.54%
Jun 30, 2022 -931.50%
Mar 31, 2022 -1,290.80%
Dec 31, 2021 -170.40%
Sep 30, 2021 -111.86%
Jun 30, 2021 -214.17%
Mar 31, 2021 -62.78%
Dec 31, 2020 -39.70%
Sep 30, 2020 -30.28%
Jun 30, 2020 -46.30%
Mar 31, 2020 -2.89%
API Access

XBiotech EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY